Delivery Order SPE2DB24D1021-SPE2DB25FFANY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,101.78 to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, which serves...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,181.89 and an ultimate completion date of July 23, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Belsomra 10mg tablets (30-count) under a firm fixed-price contract valued at $1,072.12. This competitively awarded, non-set-aside delivery order is set to complete by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order for $1,630.14 to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the prescription drug BELSOMRA 15 MG TABLET 30S. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency Troop Support Medical awarded a $127,320 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes of the 10mg Belsomra sleep aid medication. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by September 15, 2023. This delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, though further details about the underlying contract...
- The Defense Logistics Agency awarded a $381,960 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes of the 10mg Belsomra sleep aid medication. To be performed in Conshohocken, Pennsylvania from September 22nd to 25th, 2023, this order was placed under an existing DLA pharmaceutical supply contract vehicle to support the military's medical readiness needs. No subcontractors or set aside designations were indicated. As a leader in distribution of pharmaceuticals...
- The Defense Logistics Agency awarded a $509 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 30 tablets of the 10 mg dosage of Belsomra, an insomnia medication. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to various Department of Defense components. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 1, 2023. No subcontractors or set aside...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,390.28 firm fixed-price contract is for the supply of Belsomra 10mg tablets, a prescription medication used to treat insomnia. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,290.36, is for the supply of the prescription medication Belsomra 20 mg tablets. It is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen, as the prime contractor, will be responsible for delivering the pharmaceutical product to the government. This order is part of a...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFANYDelivery Order
The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order represents a small-value transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen serves as a prime pharmaceutical distributor supporting federal medical procurement across military and veteran healthcare systems, supplying a comprehensive range of branded and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse pharmaceutical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/11/25 |